documents: FDA-2020-D-1137-0112

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2020-D-1137-0112 FDA FDA-2020-D-1137 Policy for Certain REMS Requirements During the Tocilizumab Shortage Related to the COVID-19 Public Health Emergency; Guidance for Industry and Health Care Professionals Other Guidance 2022-01-21T05:00:00Z 2022 1 2022-01-21T05:00:00Z   2024-11-07T00:36:13Z   1 0 0900006484f2d2c6

Links from other tables